Global Sleeping Aids Market – Analysis and Forecast (2018-2024)
Disruption in sleep caused due to factors such as environmental problems, psychiatric disorders, medical issues, and others, is known as the sleep disorder. Sleeping aids are the devices or medication used to induce sleep. It is used in the treatment of various sleeping disorders such as insomnia, sleepwalking, and sleep apnea. Download Free Report Sample At: https://www.vynzresearch.com/healthcare/sleeping-aids-market/request-sample Mounting occurrence of insomnia and obstructive sleep apnea disorders (OSA), changing lifestyle, escalating usage of portable sleep apnea devices, and mounting government support for startup companies are the primary growth drivers for sleeping aids market. For instance, according to the Sleep Health Foundation, approximately one in three people have at least mild insomnia. Mounting disposable income, an upsurge in awareness about the adverse effect of sleep disorder, expanding the geriatric population, stressful work condition, and escalating healthcare facilities are also facilitating the growth of the sleeping aids market. Geographically, North America is the largest sleeping aids market as in the region the occurrence of sleep disorder is increasing. In addition, escalating initiatives by numerous government and non-government organizations, the upsurge in the adoption of sleeping aid products, and mounting alertness about sleep disorders and sleep hygiene are also up surging growth of the North American sleeping aids market. Asia-Pacific is observed to witness the fastest growth in the market, due to expanding the geriatric population. In addition, the mounting occurrence of sleep disorder, mounting alertness about sleeping aids products, and changing lifestyle are also creating a positive impact on the sleeping aids market growth in the region. Read More: https://www.vynzresearch.com/healthcare/sleeping-aids-market Key players in the sleeping aids market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In May 2018, Royal Philips acquired NightBalance, to expand its product portfolio in respiratory and sleep care and its position in the home care market. Sanofi, SleepMed Inc., Tempur Sealy International Inc., Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Cadwell Laboratories Inc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Compumedics Limited, Natus Medical Incorporated, Serta Simmons Bedding LLC, and Drive DeVilbiss Healthcare are the key players offering sleeping aids.
78 views • 6 slides
